Alembic Pharmaceuticals gains FDA approval for Icatibant Injection
Alembic Pharmaceuticals Limited has achieved a significant milestone with the US Food & Drug Administration’s (USFDA) final approval of its Abbreviated New Drug Application (ANDA) ... Read More
Glenmark Pharmaceuticals to tap into $290m market with FDA approval for eye treatment solution
In a significant development for Glenmark Pharmaceuticals Ltd., the company has received final approval from the United States Food & Drug Administration (U.S. FDA) for ... Read More
Zydus Lifesciences launches Mirabegron Extended-Release Tablets in US market
Zydus Lifesciences Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the US market, following the final approval from the United States ... Read More
Mylan launches generic Estradiol Vaginal Cream after securing FDA approval
Mylan, a global pharmaceutical company, has recently announced the U.S. Food and Drug Administration (FDA) approval of its Estradiol Vaginal Cream USP, 0.01%, a generic ... Read More